ARTICLE | Company News
Merrimack sales and marketing update
April 4, 2016 7:00 AM UTC
The 2016 National Comprehensive Cancer Network (NCCN) guidelines will include Merrimack’s Onivyde irinotecan ( MM-398) in combination with fluorouracil and leucovorin to treat metastatic pancreatic c...